• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用X射线衍射技术进行仿生药物研发、制剂研究及多晶型表征。

Using X-ray Diffraction Techniques for Biomimetic Drug Development, Formulation, and Polymorphic Characterization.

作者信息

Rodríguez Israel, Gautam Ritika, Tinoco Arthur D

机构信息

Department of Chemistry, University of Puerto Rico Río Piedras, San Juan, PR 00925, USA.

Department of Chemistry, Indian Institute of Technology Kanpur, Kanpur 208016, India.

出版信息

Biomimetics (Basel). 2020 Dec 30;6(1):1. doi: 10.3390/biomimetics6010001.

DOI:10.3390/biomimetics6010001
PMID:33396786
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7838816/
Abstract

Drug development is a decades-long, multibillion dollar investment that often limits itself. To decrease the time to drug approval, efforts are focused on drug targets and drug formulation for optimal biocompatibility and efficacy. X-ray structural characterization approaches have catalyzed the drug discovery and design process. Single crystal X-ray diffraction (SCXRD) reveals important structural details and molecular interactions for the manifestation of a disease or for therapeutic effect. Powder X-ray diffraction (PXRD) has provided a method to determine the different phases, purity, and stability of biological drug compounds that possess crystallinity. Recently, synchrotron sources have enabled wider access to the study of noncrystalline or amorphous solids. One valuable technique employed to determine atomic arrangements and local atom ordering of amorphous materials is the pair distribution function (PDF). PDF has been used in the study of amorphous solid dispersions (ASDs). ASDs are made up of an active pharmaceutical ingredient (API) within a drug dispersed at the molecular level in an amorphous polymeric carrier. This information is vital for appropriate formulation of a drug for stability, administration, and efficacy purposes. Natural or biomimetic products are often used as the API or the formulation agent. This review profiles the deep insights that X-ray structural techniques and associated analytical methods can offer in the development of a drug.

摘要

药物研发是一项长达数十年、耗资数十亿美元的投资,且常常受到自身限制。为了缩短药物获批时间,人们将精力集中在药物靶点和药物制剂上,以实现最佳的生物相容性和疗效。X射线结构表征方法推动了药物发现和设计过程。单晶X射线衍射(SCXRD)揭示了疾病表现或治疗效果所涉及的重要结构细节和分子相互作用。粉末X射线衍射(PXRD)提供了一种确定具有结晶性的生物药物化合物不同物相、纯度和稳定性的方法。最近,同步辐射源使人们能够更广泛地研究非晶态或无定形固体。用于确定无定形材料原子排列和局部原子有序性的一项有价值的技术是对分布函数(PDF)。PDF已被用于无定形固体分散体(ASD)的研究。ASD由活性药物成分(API)组成,并以分子水平分散在无定形聚合物载体中的药物。这些信息对于为实现稳定性、给药和疗效目的而合理配制药物至关重要。天然或仿生产品常被用作API或制剂剂。本综述概述了X射线结构技术及相关分析方法在药物研发中所能提供的深刻见解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/371d/7838816/c34bcf985b4c/biomimetics-06-00001-g013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/371d/7838816/5703a863c33a/biomimetics-06-00001-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/371d/7838816/7ba3975fef8b/biomimetics-06-00001-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/371d/7838816/08b30e992abf/biomimetics-06-00001-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/371d/7838816/5c4d30b93e83/biomimetics-06-00001-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/371d/7838816/7cadd1e913c4/biomimetics-06-00001-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/371d/7838816/b6850cd124e8/biomimetics-06-00001-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/371d/7838816/ff0e8a355d99/biomimetics-06-00001-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/371d/7838816/dd79ffb36f32/biomimetics-06-00001-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/371d/7838816/57c8902c787b/biomimetics-06-00001-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/371d/7838816/2d3e79e58141/biomimetics-06-00001-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/371d/7838816/cba07379091e/biomimetics-06-00001-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/371d/7838816/0504eafd2a1a/biomimetics-06-00001-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/371d/7838816/c34bcf985b4c/biomimetics-06-00001-g013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/371d/7838816/5703a863c33a/biomimetics-06-00001-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/371d/7838816/7ba3975fef8b/biomimetics-06-00001-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/371d/7838816/08b30e992abf/biomimetics-06-00001-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/371d/7838816/5c4d30b93e83/biomimetics-06-00001-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/371d/7838816/7cadd1e913c4/biomimetics-06-00001-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/371d/7838816/b6850cd124e8/biomimetics-06-00001-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/371d/7838816/ff0e8a355d99/biomimetics-06-00001-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/371d/7838816/dd79ffb36f32/biomimetics-06-00001-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/371d/7838816/57c8902c787b/biomimetics-06-00001-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/371d/7838816/2d3e79e58141/biomimetics-06-00001-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/371d/7838816/cba07379091e/biomimetics-06-00001-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/371d/7838816/0504eafd2a1a/biomimetics-06-00001-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/371d/7838816/c34bcf985b4c/biomimetics-06-00001-g013.jpg

相似文献

1
Using X-ray Diffraction Techniques for Biomimetic Drug Development, Formulation, and Polymorphic Characterization.利用X射线衍射技术进行仿生药物研发、制剂研究及多晶型表征。
Biomimetics (Basel). 2020 Dec 30;6(1):1. doi: 10.3390/biomimetics6010001.
2
Comparison of Differential Scanning Calorimetry, Powder X-ray Diffraction, and Solid-state Nuclear Magnetic Resonance Spectroscopy for Measuring Crystallinity in Amorphous Solid Dispersions - Application to Drug-in-polymer Solubility.差示扫描量热法、粉末X射线衍射法和固态核磁共振光谱法用于测定无定形固体分散体结晶度的比较——在药物-聚合物溶解度中的应用
J Pharm Sci. 2022 Oct;111(10):2765-2778. doi: 10.1016/j.xphs.2022.04.004. Epub 2022 Apr 11.
3
Characterization of Amorphous Solid Dispersions and Identification of Low Levels of Crystallinity by Transmission Electron Microscopy.通过透射电子显微镜对无定形固体分散体进行表征和对低水平结晶度进行鉴定。
Mol Pharm. 2021 May 3;18(5):1905-1919. doi: 10.1021/acs.molpharmaceut.0c00918. Epub 2021 Apr 2.
4
Spray drying ternary amorphous solid dispersions of ibuprofen - An investigation into critical formulation and processing parameters.喷雾干燥布洛芬三元无定形固体分散体:关键配方和工艺参数研究。
Eur J Pharm Biopharm. 2017 Nov;120:43-51. doi: 10.1016/j.ejpb.2017.08.005. Epub 2017 Aug 16.
5
Combining crystalline and polymeric excipients in API solid dispersions - Opportunity or risk?将晶型和聚合型辅料组合在原料药固体分散体中-机遇还是风险?
Eur J Pharm Biopharm. 2021 Jan;158:323-335. doi: 10.1016/j.ejpb.2020.11.025. Epub 2020 Dec 6.
6
Probing Molecular Packing of Amorphous Pharmaceutical Solids Using X-ray Atomic Pair Distribution Function and Solid-State NMR.利用 X 射线原子配分函数和固态 NMR 研究无定形药物固体的分子堆积
Mol Pharm. 2023 Nov 6;20(11):5763-5777. doi: 10.1021/acs.molpharmaceut.3c00628. Epub 2023 Oct 6.
7
Analysis of amorphous and nanocrystalline solids from their X-ray diffraction patterns.通过X射线衍射图谱分析非晶态和纳米晶态固体。
Pharm Res. 2006 Oct;23(10):2333-49. doi: 10.1007/s11095-006-9086-2. Epub 2006 Sep 22.
8
Spray Encapsulation as a Formulation Strategy for Drug-Based Room Temperature Ionic Liquids: Exploiting Drug-Polymer Immiscibility to Enable Processing for Solid Dosage Forms.喷雾包封作为基于药物的室温离子液体的配方策略:利用药物-聚合物不混溶性来实现固体剂型的加工。
Mol Pharm. 2020 Sep 8;17(9):3412-3424. doi: 10.1021/acs.molpharmaceut.0c00467. Epub 2020 Aug 27.
9
Evaluation of Suitable Polymeric Matrix/Carriers during Loading of Poorly Water Soluble Drugs onto Mesoporous Silica: Physical Stability and In Vitro Supersaturation.难溶性药物负载于介孔二氧化硅过程中合适聚合物基质/载体的评估:物理稳定性和体外过饱和现象
Polymers (Basel). 2024 Mar 13;16(6):802. doi: 10.3390/polym16060802.
10
Solid-state characterization of amorphous and mesomorphous calcium ketoprofen.无定形和中间相态的钙酮洛芬的固态特性研究。
J Pharm Sci. 2010 Sep;99(9):3684-97. doi: 10.1002/jps.21925.

引用本文的文献

1
Synthesis and characterization of protein nanohybrid systems for the brain delivery of Riluzole.用于利鲁唑脑递送的蛋白质纳米杂化系统的合成与表征
Ther Deliv. 2025 Jun;16(6):569-579. doi: 10.1080/20415990.2025.2478805. Epub 2025 Mar 24.
2
The usefulness of infrared spectroscopy and X-ray powder diffraction in the analysis of falsified, illegal, and medicinal products.红外光谱法和X射线粉末衍射法在分析假药、非法药品和药用产品中的应用。
Front Chem. 2025 Feb 19;13:1536209. doi: 10.3389/fchem.2025.1536209. eCollection 2025.
3
Advancing the Physicochemical Properties and Therapeutic Potential of Plant Extracts Through Amorphous Solid Dispersion Systems.

本文引用的文献

1
Exploring Serum Transferrin Regulation of Nonferric Metal Therapeutic Function and Toxicity.探索血清转铁蛋白对非铁金属治疗功能和毒性的调节作用。
Inorganics (Basel). 2020 Sep;8(9). doi: 10.3390/inorganics8090048. Epub 2020 Aug 29.
2
Metal-binding effects of sirtuin inhibitor sirtinol.沉默调节蛋白抑制剂西托辛醇的金属结合效应
Supramol Chem. 2016;28(1-2):108-116. doi: 10.1080/10610278.2015.1092537. Epub 2015 Oct 15.
3
Iron and Copper Intracellular Chelation as an Anticancer Drug Strategy.铁和铜细胞内螯合作为一种抗癌药物策略
通过无定形固体分散体系统提升植物提取物的物理化学性质及治疗潜力
Polymers (Basel). 2024 Dec 14;16(24):3489. doi: 10.3390/polym16243489.
4
Sofosbuvir Polymorphs Distinguished by Linearly and Circularly Polarized Raman Microscopy.通过线性和圆偏振拉曼显微镜区分的索磷布韦多晶型物。
Anal Chem. 2024 Dec 3;96(48):18983-18993. doi: 10.1021/acs.analchem.4c03573. Epub 2024 Nov 21.
5
Synthesis, crystal structure, biological and docking studies of 5-hydroxy-2-{[(2-methylpropyl)iminio]methyl}phenolate.5-羟基-2-{[(2-甲基丙基)亚氨基]甲基}苯酚盐的合成、晶体结构、生物及对接研究。
Future Med Chem. 2024;16(19):1983-1997. doi: 10.1080/17568919.2024.2389763. Epub 2024 Sep 11.
6
Synthesis and characterization of fullerene-based nanocarrier for targeted delivery of quercetin to the brain.富勒烯基纳米载体的合成与表征及其用于槲皮素向脑部的靶向递送
Ther Deliv. 2024;15(7):545-559. doi: 10.1080/20415990.2024.2365620. Epub 2024 Sep 5.
7
Small-Angle X-ray Scattering (SAXS) Used for the Identification of Nicomorphine Polymorphic Changes at the Early Stage to Avoid Varied Stability and Possible Side Effects.小角X射线散射(SAXS)用于早期识别尼可吗啡的多晶型变化,以避免稳定性差异和可能的副作用。
Pharmaceuticals (Basel). 2024 Mar 15;17(3):375. doi: 10.3390/ph17030375.
8
Exploring high-throughput synchrotron X-Ray powder diffraction for the structural analysis of pharmaceuticals.探索高通量同步加速器X射线粉末衍射用于药物的结构分析。
Int J Pharm X. 2023 Nov 29;6:100221. doi: 10.1016/j.ijpx.2023.100221. eCollection 2023 Dec 15.
9
Multiple Natural Polymers in Drug and Gene Delivery Systems.多天然聚合物在药物和基因传递系统中的应用。
Curr Med Chem. 2024;31(13):1691-1715. doi: 10.2174/0929867330666230316094540.
Inorganics (Basel). 2018;6(4). doi: 10.3390/inorganics6040126. Epub 2018 Nov 30.
4
NMR as a "Gold Standard" Method in Drug Design and Discovery.NMR 作为药物设计和发现的“金标准”方法。
Molecules. 2020 Oct 9;25(20):4597. doi: 10.3390/molecules25204597.
5
Editorial: Using Cancer 'Omics' to Understand Cancer.社论:利用癌症“组学”理解癌症
Front Oncol. 2020 Jul 24;10:1201. doi: 10.3389/fonc.2020.01201. eCollection 2020.
6
Paramagnetic NMR in drug discovery.顺磁 NMR 在药物研发中的应用。
J Biomol NMR. 2020 Jul;74(6-7):287-309. doi: 10.1007/s10858-020-00322-0. Epub 2020 Jun 10.
7
Formulation and Characterization of Solid Dispersions of Etoricoxib Using Natural Polymers.依托考昔用天然聚合物的固体分散体的制剂与表征
Turk J Pharm Sci. 2020 Feb;17(1):7-19. doi: 10.4274/tjps.galenos.2018.04880. Epub 2020 Feb 19.
8
A Review on Applications of Computational Methods in Drug Screening and Design.计算方法在药物筛选和设计中的应用综述。
Molecules. 2020 Mar 18;25(6):1375. doi: 10.3390/molecules25061375.
9
CRISPR-engineered T cells in patients with refractory cancer.经 CRISPR 基因编辑的 T 细胞治疗难治性癌症的患者。
Science. 2020 Feb 28;367(6481). doi: 10.1126/science.aba7365. Epub 2020 Feb 6.
10
Informatics and Computational Methods in Natural Product Drug Discovery: A Review and Perspectives.天然产物药物发现中的信息学与计算方法:综述与展望
Front Genet. 2019 Apr 30;10:368. doi: 10.3389/fgene.2019.00368. eCollection 2019.